U.S. Congress - Letters to Congress: S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012
A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs.
The following letters were written by OpenCongress.org users and sent to their elected representatives. You can start a letter of your own by clicking the links to right.
-
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
emily_luedtke
May 22, 2012
I am writing as your constituent in the 4th Congressional district of Maryland. I am writing as your constituent in the 4th Congressional district of Maryland. I support S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
Sincerely,
Emily Luedtke -
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
mjdmaz
May 22, 2012
I am writing as your constituent in the 7th Congressional district of Maryland. I support S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
Sincerely,
Maryjean Mazzafro -
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
jpelesh1973
May 22, 2012
I am writing as your constituent in the 7th Congressional district of Maryland. I am writing as your constituent in the 7th Congressional district of Maryland. I support S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
Sincerely,
Jennifer Pelesh -
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
Tgjanet
May 22, 2012
I am writing as your constituent in the 7th Congressional district of Maryland. I am writing as your constituent in the 7th Congressional district of Maryland. I support S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012, and am tracking it using OpenCongress.org, the free public resource website for government transparency and accountability.
Sincerely,
Janet Bahouth -
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
HisAngel
May 21, 2012
I am writing as your constituent in the 4th Congressional district of Missouri. I am writing as your constituent in the 4th Congressional district of Missouri. I am writing as your constituent in the 4th Congressional district of Missouri. I am writing as your constituent in the 4th Congressional district of Missouri. I am writing as your constituent in the 4th Congressional district of Missouri. I am writing as your constituent in the 4th Congressional district of Missouri. I am writin...
-
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
schr0469
May 21, 2012
I am writing as your constituent in support of S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012. My 4 year old son has a genetic disease called cystic fibrosis. Recently, he was able to begin treatment with a newly FDA approved drug called Kalydeco. This treatment has been a life changing miracle for us. Kalydeco was developed to treat our son's specific genetic mutation of CF (of which there are over 1900). Other compounds are advancing through the drug development pipe...
-
S.2236 Advancing Breakthrough Therapies for Patients Act of 2012
beckyboo1223
May 01, 2012
I am writing as your constituent in the 7th Congressional district of Colorado. I'm tracking S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012 using OpenCongress.org, the free public resource website for government transparency and accountability.
Sincerely,
Rebecca Sours
Vote on This Bill
-
Share This Bill
More Share via Email
